Imagion Biosystems (ASX:IBX) gets ready for Phase 2
It’s taken a while to get here, but the US medical device company Imagion Biosystems (ASX: IBX), which listed on…
Here are some ASX directors who sold shares recently and some of the intriguing reasons why
Here are some ASX directors who sold shares recently Jack Gance – Sigma Healthcare (ASX:SIG) a.k.a. Chemist Warehouse Jack Gance…
Plenti (ASX:PLT): Offering investors exposure to the energy transition, but without the high capex
Plenti (ASX:PLT) is not just another small cap lender – it could be the best way to gain exposure to…
Emyria’s (ASX:EMD) commercial breakthrough in psychedelic medicine
When Perth-based Emyria (ASX:EMD) announced on 18 June that Medibank would be funding eligible customer participation in Emyria’s Post-Traumatic Stress…
XRG Eyes Defence Payday? VR Firm’s US Contract Flow Signals New Growth Arc
xReality Group (ASX: XRG) is no longer just a speculative play on virtual reality entertainment. The company recently secured an…
Locksley Resources (ASX: LKY) Jumps 15% on Antimony Supply Deal
Locksley Resources — Antimony Supply Agreement Expands U.S. Critical Minerals Strategy Locksley Resources (ASX: LKY) caught investors’ attention this morning…
OFX (ASX:OFX): After backflipping on its growth promises and spending months in the doldrums, maybe there’s light at the end of the tunnel?
OFX (ASX:OFX) shares shed more than two thirds of their value from October 2024 to June 2025 after a weak…
Artrya (ASX:AYA): With FDA 510(k) approval and $75m in fresh capital, its all systems go!
4 years after listing and over 7 years after its founding, Artrya (ASX:AYA) achieved the aspiration of most ASX medtechs,…
6 ASX stocks that Australian Ethical bought or sold recently
We often like to look at shares that well known ASX fund managers are trading, and today we’re looking at…
Fed Decision Preview: Political Heat, Cooling Jobs — 25 or 50 bps?
As the Federal Reserve prepares to announce its next move on September 17, 2025, markets are anticipating a potential rate…
Apple Event: Buy, Sell, or Hold? What the ‘Awe Dropping’ Launch Means for Investors
Apple’s product launches are typically major events in the tech world, and their latest “Awe Dropping” launch is no exception.…
HeraMED Hits Milestones with A$2 M Placement and Quarterly Report: Is the Rebound On?
HeraMED (ASX: HMD) has re-entered the spotlight with two significant announcements: a successful A$2 million placement and the release of…
Airtasker Launches Investor Hub Amid Media Push: Is It Gearing Up for Scale?
When Airtasker (ASX: ART) announced the launch of a new Investor Hub and unveiled a set of fresh media partnerships,…
Great Northern Minerals gets its kicks near Route 66
When Great Northern Minerals (ASX:GNM) announced on 22 August 2025 that it had made a ‘strategic acquisition of a REE-antimony…
Sprintex Revamps: New Deal in Türkiye and Capital Move Fuel Growth Strategy
Sprintex (ASX: SIX) has jolted back into the investor spotlight with two announcements that could reshape its growth trajectory. The…